D-0745-2026 Class II Ongoing
FDA drug recall D-0745-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Aug 5, 2026 and is designated Class II. Reason for recall: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 12, 2026
- Initiation Date
- Aug 5, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.
Reason for recall
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Distribution pattern
Nationwide in the USA
Code information
Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0745-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026